Parkinsonism Post BCMA-Directed CAR-T Therapy in Multiple Myeloma Patients: A Real-World Analysis

Key Points

• Parkinsonism emerges as a notable outcome following BCMA-directed CAR-T therapy.
• In a sample of multiple myeloma patients, a significant link to neurotoxicity was observed.
• This analysis used a longitudinal study framework to assess patient outcomes post-therapy.
• Findings highlight the importance of ongoing surveillance for neurological effects after CAR-T treatment.